Loading…
Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis
Abstract Background Postoperative ileus is a common problem after colorectal surgery. The aim of the study was to investigate the incidence and risk factors for prolonged postoperative ileus (POI) after colectomy for inflammatory bowel diseases (IBD). Method Consecutive patients who underwent colore...
Saved in:
Published in: | The Journal of surgical research 2017-05, Vol.212, p.86-93 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Background Postoperative ileus is a common problem after colorectal surgery. The aim of the study was to investigate the incidence and risk factors for prolonged postoperative ileus (POI) after colectomy for inflammatory bowel diseases (IBD). Method Consecutive patients who underwent colorectal resection for IBD vs. colorectal cancer (CRC) patients under enhanced recovery after surgery (ERAS) protocol were retrospectively analyzed. Primary assessment endpoint is the incidence of prolonged POI (> 4 days); secondary endpoints were GI-2 recovery (time to first toleration of solid food and first bowel movement), nasogastric tube re-insertion, and postoperative length of stay. Risk factors for prolonged POI in IBD patients were assessed by multiple logistic regression analysis with p-score matching. Results The incidence of prolonged POI was higher in IBD vs. CRC group (28.8 vs. 14.8%, P < 0.001). Patients with IBD had a longer time to GI-2 recovery (4.8±2.1 vs 3.7 ± 1.4 d, P < 0.001), postoperative length of stay (10.7 ± 6.2 vs. 7.9 ± 5.3 d, P < 0.001), higher incidence of nasogastric tube re-insertion (9.8 vs. 4.0%, P = 0.02). After propensity-score matching analysis, the differences were still significant. Preoperative steroid use > 20mg/d (OR = 2.19, P =0.048), hypo-albuminemia ( |
---|---|
ISSN: | 0022-4804 1095-8673 |
DOI: | 10.1016/j.jss.2016.12.031 |